ALNYLAM PHARMACEUTICALS, INC. (MA)
Registration and award facts
SAM.gov registration as of
Net obligations recorded since FY2008 under this UEI: $12,301,819 across 2 awards and orders with positive net obligations.
- Net obligations since FY2008
- $12.30M
- $12,301,819under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 2
- with positive net obligations2 IDV vehicles held
- Latest action
- May 12, 2026
- SAM.gov registration
- Inactive
- Registration expiration date Dec 30, 2020
Registration
- UEI
- GTKHWKZJSX53
- CAGE code
- 45SR1
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Jun 14, 2002 (24 years)
- Location
- Cambridge, MA
- State of incorporation
- Delaware
- Purpose of registration
- All Awards
SBA certifications
No certification in the SBA profile data.
NAICS codes
- 325412Pharmaceutical Preparation Manufacturing(primary)Small
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Small
Small: small business for that NAICS, self-certified in SAM.gov registration.
Product and service codes (PSC)
- AJ52R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Federal contract obligations
Net obligations recorded under this UEI since FY2008. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2014: -$90,640 (de-obligation)
- FY2009: $1,227,753
- FY2008: $11,164,706
Total across 3 fiscal years: $12,301,819
Net de-obligation in that fiscal year (obligations withdrawn).
Top awarding agencies
- Department of Health and Human Services$8,775,751, 71.3%
- Department of Defense$3,526,068, 28.7%
Top awarding sub-agencies
- National Institutes of Health$8,775,751, 71.3%
- Defense Threat Reduction Agency$3,526,068, 28.7%
Top NAICS by obligations
- 541710$8,685,111, 70.6%
Top product and service codes by obligations
- AN22R&d-drug dependency-a res/expl dev$8,775,751, 71.3%
- 6505Drugs and biologicals$3,526,068, 28.7%
† FY2026 obligations (provisional; DoD awards signed after Jul 22, 2026 are not yet public).
Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 22, 2026 are not yet public.
Latest awards and orders
- 36F79719D0074Federal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
- HHSN266200600012CDefinitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
- 36F79718D018EFederal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
- HDTRA107C0082Definitive contractDepartment of DefenseDefense Threat Reduction AgencyLatest action
Other contractors in Massachusetts with primary NAICS 325412
- Partner Therapeutics, Inc.Lexington, MA
- Progenics Pharmaceuticals IncBedford, MA
- Vericel CorporationCambridge, MA
- Lantheus Medical Imaging, Inc.Bedford, MA
- Takeda Pharmaceuticals America, Inc.Cambridge, MA
- Alexion Pharmaceuticals IncBoston, MA
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI GTKHWKZJSX53. GovChime does not check exclusions.
Key Performance Statistics
View obligations by year, agencies and performance history
Capabilities
NAICS Codes
See all industry codes with contract counts
Product/Service Codes
As of . Source: SAM.gov Goods & Services.
Certifications
Business Types
Contracts
Explore federal contract awards with detailed transaction history
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for ALNYLAM PHARMACEUTICALS, INC. lists a physical address and a separate mailing address, along with 5 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
300 3RD ST
CAMBRIDGE, MA, 02142
USA
Mailing Address
300 3RD STREET, 3RD FLOOR
CAMBRIDGE, MA, 02142
USA
Government Business Contact
Lisa Kiniklis
300 Third Street
Cambridge, MA, 02142
USA
Electronic Business Contact
Lisa Kiniklis
300 Third Street
Cambridge , MA, 02142
USA
Past Performance Contact
Gina Tracey
300 Third Street
Cambridge, MA, 02142
USA
Government Business Alternate Contact
Gina Tracey
300 THIRD ST
CAMBRIDGE, MA, 02142
USA
Electronic Business Alternate Contact
Gina Tracey
300 THIRD ST
CAMBRIDGE, MA, 02142
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
ALNYLAM PHARMACEUTICALS, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires December 30, 2020.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govDate Founded
Initial Registration
Last Update
Registration Activation
Registration Expiration
Fiscal Year End
State of Incorporation
Country of Incorporation
Congressional District